Avalon Investment & Advisory Vertex Pharmaceuticals Inc Transaction History

Avalon Investment & Advisory

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 08, 2021	SELL	$181.39 - $202.99 $968,622 - $1.08 Million	-5,340 Closed	0 $0
Q2 2021 Jul 29, 2021	SELL	$187.49 - $221.1 $54,372 - $64,119	-290 Reduced 5.15%	5,340 $1.08 Million
Q1 2021 May 13, 2021	SELL	$207.02 - $241.31 $51,962 - $60,568	-251 Reduced 4.27%	5,630 $1.21 Million
Q4 2020 Feb 08, 2021	SELL	$207.01 - $276.09 $6.47 Million - $8.62 Million	-31,232 Reduced 84.15%	5,881 $1.39 Million
Q3 2020 Nov 04, 2020	SELL	$255.65 - $303.1 $149,810 - $177,616	-586 Reduced 1.55%	37,113 $10.1 Million
Q2 2020 Aug 07, 2020	SELL	$225.48 - $295.8 $554,455 - $727,372	-2,459 Reduced 6.12%	37,699 $10.9 Million
Q1 2020 May 05, 2020	BUY	$199.77 - $247.81 $8.02 Million - $9.95 Million	40,158 New	40,158 $9.56 Million

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Avalon Investment & Advisory, based on Form 13F filings with the SEC.

Stay updated on Avalon Investment & Advisory with notifications on news.